Systematic review of efficacy and safety of Compound Danshen Injection combined with Western medicine in treatment of vascular dementia.
10.19540/j.cnki.cjcmm.20200317.501
- Author:
Xin-Xin CHEN
1
;
Xin-Yao JIN
2
;
Wen-Tai PANG
2
;
Nan LI
2
;
Ke-Yi WANG
2
;
Wen-Ke ZHENG
2
Author Information
1. Tianjin University of Traditional Chinese Medicine Tianjin 301617, China.
2. Tianjin University of Traditional Chinese Medicine Tianjin 301617, China Center for Evidence-based Medicine, Tianjin University of Traditional Chinese Medicine Tianjin 301617, China.
- Publication Type:Systematic Review
- Keywords:
Compound Danshen Injection;
Meta-analysis;
efficacy;
safety;
systematic review;
vascular dementia
- MeSH:
Dementia, Vascular/drug therapy*;
Drugs, Chinese Herbal/adverse effects*;
Humans;
Injections;
Medicine;
Salvia miltiorrhiza
- From:
China Journal of Chinese Materia Medica
2021;46(1):247-252
- CountryChina
- Language:Chinese
-
Abstract:
To evaluate the efficacy and safety of Compound Danshen Injection combined with Western medicine in the treatment of vascular dementia. Databases of Cochrane Library, PubMed, EMbase, CNKI, SinoMed, VIP, Wanfang Data were electronically retrieved for collecting randomized controlled trial(RCT)about vascular dementia treated with Western medicine alone or combined with Compound Danshen Injection from the year of database establishment to January 2020. Two researchers independently screened out li-teratures, extracted data, and evaluated the risk of bias for inclusion in the study. Meta-analysis was conducted using RevMan 5.3 software. A total of 5 RCTs were included, involving 588 patients, with 299 in treatment group and 289 in control group. Meta-analysis results showed that compared with Western medicine alone, Compound Danshen Injection combined with Western medicine was better in the effective rate(RR=1.23,95%CI[1.14,1.33],P<0.000 01), MMSE score(MD=3.54,95%CI[3.01,4.06],P<0.000 01), ADL score(MD=11.49,95%CI[8.05,14.93],P<0.000 01), the level of CRP(MD=-0.72,95%CI[-1.25,-0.20],P=0.007) and the level of IL-6(MD=-7.64,95%CI[-9.65,-5.63],P<0.000 01). Adverse reactions mainly included rash and skin prick, which did not affect the treatment effect. Based on the findings, the combination of Compound Danshen Injection in the treatment of vascular dementia could improve the effective rates, relieve the mental state damage and improve the daily living ability, with mild adverse reactions and a low incidence. However, due to the low quality of the included literatures, high-quality and large-scale randomized controlled trials are needed for further verification.
